Want to see HK:1763 full AI Analyst Report?
China Isotope & Radiation Corp. (1763) Ratios
China Isotope & Radiation Corp. Ratios
HK:1763's free cash flow for Q2 2026 was $-149.50M. For the 2026 fiscal year, HK:1763's free cash flow was decreased by $-214.42M and operating cash flow was $64.93M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.76 | 1.78 | 1.93 | 1.88 | 1.68 |
| Quick Ratio | 1.51 | 1.58 | 1.73 | 1.65 | 1.45 |
| Cash Ratio | 0.49 | 0.52 | 0.68 | 0.73 | 0.69 |
| Solvency Ratio | 0.08 | 0.09 | 0.10 | 0.11 | 0.11 |
| Operating Cash Flow Ratio | 0.10 | 0.03 | 0.02 | 0.22 | 0.20 |
| Short-Term Operating Cash Flow Coverage | 0.60 | 0.15 | 0.43 | 23.19 | 1.29 |
| Net Current Asset Value | $ 1.75B | $ 1.90B | $ 2.14B | $ 2.38B | $ 2.21B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.17 | 0.17 | 0.13 | 0.08 | 0.08 |
| Debt-to-Equity Ratio | 0.52 | 0.51 | 0.36 | 0.20 | 0.20 |
| Debt-to-Capital Ratio | 0.34 | 0.34 | 0.27 | 0.17 | 0.17 |
| Long-Term Debt-to-Capital Ratio | 0.25 | 0.24 | 0.24 | 0.15 | 0.03 |
| Financial Leverage Ratio | 3.01 | 2.95 | 2.81 | 2.62 | 2.51 |
| Debt Service Coverage Ratio | 0.88 | 1.13 | 4.63 | 12.25 | 1.18 |
| Interest Coverage Ratio | 13.24 | 22.44 | 26.05 | 25.86 | 21.73 |
| Debt to Market Cap | 0.46 | 0.76 | 0.44 | 0.22 | 0.13 |
| Interest Debt Per Share | 8.74 | 8.18 | 5.41 | 2.94 | 2.79 |
| Net Debt to EBITDA | 0.11 | -0.05 | -0.96 | -1.92 | -2.10 |
| Profitability Margins | |||||
| Gross Profit Margin | 50.31% | 48.62% | 52.48% | 57.18% | 63.03% |
| EBIT Margin | 13.09% | 14.00% | 14.45% | 14.23% | 14.44% |
| EBITDA Margin | 16.86% | 16.95% | 18.43% | 17.15% | 17.52% |
| Operating Profit Margin | 13.09% | 14.34% | 14.19% | 14.87% | 15.12% |
| Pretax Profit Margin | 13.97% | 13.80% | 13.90% | 14.98% | 15.61% |
| Net Profit Margin | 4.56% | 5.37% | 5.59% | 6.38% | 6.53% |
| Continuous Operations Profit Margin | 9.25% | 11.61% | 11.70% | 12.29% | 13.08% |
| Net Income Per EBT | 32.61% | 38.91% | 40.22% | 42.61% | 41.83% |
| EBT Per EBIT | 106.76% | 96.21% | 97.97% | 100.72% | 103.20% |
| Return on Assets (ROA) | 2.03% | 2.75% | 2.81% | 3.36% | 3.21% |
| Return on Equity (ROE) | 6.10% | 8.12% | 7.90% | 8.78% | 8.03% |
| Return on Capital Employed (ROCE) | 8.78% | 11.15% | 10.54% | 11.87% | 11.96% |
| Return on Invested Capital (ROIC) | 5.34% | 8.54% | 8.65% | 10.07% | 9.50% |
| Return on Tangible Assets | 2.10% | 2.83% | 2.88% | 3.41% | 3.27% |
| Earnings Yield | 5.50% | 12.46% | 9.85% | 10.38% | 5.86% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.43 | 1.49 | 1.70 | 1.74 | 1.80 |
| Payables Turnover | 4.84 | 4.92 | 5.03 | 5.33 | 5.63 |
| Inventory Turnover | 2.58 | 3.92 | 3.87 | 2.88 | 2.10 |
| Fixed Asset Turnover | 1.51 | 1.75 | 1.84 | 2.18 | 2.05 |
| Asset Turnover | 0.45 | 0.51 | 0.50 | 0.53 | 0.49 |
| Working Capital Turnover Ratio | 1.76 | 1.93 | 1.78 | 1.98 | 1.81 |
| Cash Conversion Cycle | 320.93 | 263.71 | 236.04 | 267.48 | 310.99 |
| Days of Sales Outstanding | 255.01 | 244.78 | 214.34 | 209.19 | 202.28 |
| Days of Inventory Outstanding | 141.39 | 93.16 | 94.26 | 126.83 | 173.55 |
| Days of Payables Outstanding | 75.46 | 74.23 | 72.55 | 68.53 | 64.84 |
| Operating Cycle | 396.39 | 337.94 | 308.59 | 336.01 | 375.83 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.68 | 0.45 | 0.27 | 2.70 | 2.48 |
| Free Cash Flow Per Share | -0.15 | 0.45 | -2.54 | 1.03 | 1.15 |
| Dividend Paid and CapEx Coverage Ratio | 0.80 | 0.12 | 0.08 | 1.32 | 1.64 |
| Capital Expenditure Coverage Ratio | 0.98 | 0.14 | 0.09 | 1.62 | 1.86 |
| Operating Cash Flow Coverage Ratio | 0.20 | 0.06 | 0.05 | 0.95 | 0.93 |
| Operating Cash Flow to Sales Ratio | 0.08 | 0.02 | 0.01 | 0.14 | 0.15 |
| Free Cash Flow Yield | -0.83% | 4.37% | -21.57% | 8.70% | 6.40% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 18.14 | 8.02 | 10.16 | 9.63 | 17.07 |
| Price-to-Sales (P/S) Ratio | 0.83 | 0.43 | 0.57 | 0.61 | 1.11 |
| Price-to-Book (P/B) Ratio | 1.11 | 0.65 | 0.80 | 0.85 | 1.37 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -119.89 | 22.90 | -4.64 | 11.50 | 15.63 |
| Price-to-Operating Cash Flow Ratio | 10.78 | 22.90 | 44.35 | 4.38 | 7.22 |
| Price-to-Earnings Growth (PEG) Ratio | -0.85 | 0.85 | -1.78 | 0.56 | 0.30 |
| Enterprise Value Multiple | 5.03 | 2.50 | 2.12 | 1.67 | 4.26 |
| Enterprise Value | 5.94B | 3.20B | 2.59B | 1.76B | 3.84B |
| EV to EBITDA | 5.03 | 2.50 | 2.12 | 1.67 | 4.26 |
| EV to Sales | 0.85 | 0.42 | 0.39 | 0.29 | 0.75 |
| EV to Free Cash Flow | -122.67 | 22.49 | -3.19 | 5.35 | 10.47 |
| EV to Operating Cash Flow | 11.03 | 22.49 | 30.49 | 2.04 | 4.83 |
| Tangible Book Value Per Share | 23.80 | 22.95 | 21.40 | 19.89 | 18.23 |
| Shareholders’ Equity Per Share | 16.35 | 15.65 | 14.67 | 13.96 | 13.07 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.34 | 0.16 | 0.16 | 0.18 | 0.16 |
| Revenue Per Share | 21.89 | 23.68 | 20.74 | 19.21 | 16.08 |
| Net Income Per Share | 1.00 | 1.27 | 1.16 | 1.23 | 1.05 |
| Tax Burden | 0.33 | 0.39 | 0.40 | 0.43 | 0.42 |
| Interest Burden | 1.07 | 0.99 | 0.96 | 1.05 | 1.08 |
| Research & Development to Revenue | 0.04 | 0.04 | 0.05 | 0.05 | 0.04 |
| SG&A to Revenue | 0.33 | 0.31 | 0.10 | 0.09 | 0.10 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.54 | 0.14 | 0.09 | 2.20 | 2.37 |
Currency in CNY